Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
45.43
+1.32 (2.99%)
At close: Apr 28, 2026, 4:00 PM EDT
45.26
-0.17 (-0.38%)
After-hours: Apr 28, 2026, 4:42 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.8 billion as of April 28, 2026. Its market cap has increased by 2,443.48% in one year.
Market Cap
2.80B
Enterprise Value
2.63B
1-Year Change
2,443.48%
Ranking
Category
Stock Price
$45.43
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.80B, an increase of 684.12%. That is a compound annual growth rate of 31.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.72B | 57.14% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 2.91B |
| Relay Therapeutics | 2.83B |
| Soleno Therapeutics | 2.73B |
| Enliven Therapeutics | 2.69B |
| Vera Therapeutics | 2.67B |
| Immunome | 2.66B |
| Celldex Therapeutics | 2.64B |
| Disc Medicine | 2.63B |